Report an error

Spotted something inaccurate in “Semaglutide Earns FDA Approval for Liver Fibrosis: Phase 3 Data Analyzed”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.